Skip to main content

August 2020 Vol 13, Special Issue: Payers' Perspectives in Oncology

Leukemia, Lymphoma, Oncology
Long-Term Data Support Use of Acalabrutinib in Treatment-Naïve Patients with Chronic Lymphocytic Leukemia
Chase Doyle
Read More
Maintenance Avelumab New Standard of Care for Advanced Bladder Cancer
Phoebe Starr
Read More
Nivolumab plus Ipilimumab May Be a New First-Line Option for Patients with MSI-H or dMMR Metastatic Colorectal Cancer
Wayne Kuznar
Read More
Pembrolizumab Doubles Progression-Free Survival in Subset of Patients with Metastatic Colorectal Cancer
Chase Doyle
Read More
Multiple Myeloma, Oncology
CAR T-Cell Therapy Shows Deep, Durable Responses in Relapsed or Refractory Multiple Myeloma
Chase Doyle
Read More
Breast Cancer, Oncology
Pembrolizumab Added to First-Line Chemotherapy Improves Progression-Free Survival in Metastatic TNBC
Wayne Kuznar
Read More
Breast Cancer, Oncology
No Survival Benefit with Surgery and Radiation Added to Systemic Therapy in Patients with Newly Diagnosed Stage IV Breast Cancer
Phoebe Starr
Read More
Prostate Cancer
Cabozantinib plus Atezolizumab Combination Shows Meaningful Activity in Metastatic Prostate Cancer
Phoebe Starr
Read More
FDA Approvals
FDA News: August 2020
Read More
Ovarian Cancer
Olaparib Extends Survival by >1 Year in Patients with Ovarian Cancer and BRCA Mutation, Ushering in Personalized Medicine in This Malignancy
Wayne Kuznar
Read More
Page 1 of 3
Results 1 - 10 of 26